Advancing the global cannabis industry

At the 2020 GCI Summit, Daniel Herrera and Sebastian Palazio discussed intercontinental trade partnerships.

The November 2020 Global Cannabis Intelligence (GCI) summit brought together stakeholders and experts from throughout the field of cannabis to share knowledge, promote collaboration and advance the global cannabis industry.

At the summit’s ‘Building a partnership between South America and Europe’ event, Daniel Herrera, Chief Corporate Development Officer of MedColCanna, and Greenstein CFO Sebastian Palazio discussed the partnership between their companies and the holistic benefits of operating in Latin America.

A lot of products need to get into various supply chains and various verticals, at the lowest cost possible, while maintaining increasingly stringent quality metrics and requirements depending on the verticals that that company wants to participate in.

What are the benefits of marijuana?

Currently, there are two synthetic versions of marijuanaTrusted Source. Doctors prescribe them for the treatment of severe epilepsy and chemotherapy side effects.

The following list of marijuana benefits are some of the most commonly discussed in scientific research, as well as anecdotally.

Pain management

The cannabinoids in marijuana may reduce pain by altering pain perception pathways in the brain. This may be helpful to treat conditions that cause chronic pain, such as:

  • Arthritis
  • Fibromyalgia
  • Endometriosis
  • Migraine

It may also minimize cancer treatment side effects, like loss of appetite.

Reduced inflammation

CBD in marijuana is thought to help reduce inflammation. In theory, this may benefit inflammatory conditions, such as:

  1. Crohn’s disease
  2. Irritable bowel syndrome
  3. Rheumatoid arthritis